Quipt Home Medical Corp. (QIPT)

Quipt Home Medical Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	264.97	245.36	245.92	211.68	127.64	94.39
Revenue Growth (YoY)	8.28%	-0.23%	16.18%	65.84%	35.22%	29.95%
Cost of Revenue	73.19	68.18	68.93	57.9	33.21	28.17
Gross Profit	191.78	177.18	176.99	153.78	94.42	66.22
Selling, General & Admin	136.63	125.46	122.54	103.22	65.2	44.66
Amortization of Goodwill & Intangibles	12.97	12.49	12.07	10.33	2.59	1.57
Other Operating Expenses	-	-	-	-	-4.89	-
Operating Expenses	195.25	181.41	175.58	149.73	88.85	67.39
Operating Income	-3.46	-4.23	1.41	4.05	5.57	-1.17
Interest Expense	-7.37	-6.29	-8.29	-5.91	-2.08	-1.99
Interest & Investment Income	0.37	0.47	0.79	0.37	-	-
Earnings From Equity Investments	-0.29	-0.32	-0.31	-0.09	-	-
Currency Exchange Gain (Loss)	0.56	-0.37	0.04	0.11	-0.14	-0.17
Other Non Operating Income (Expenses)	-	-	-	-	-	-2.11
EBT Excluding Unusual Items	-10.19	-10.75	-6.36	-1.48	3.35	-5.45
Merger & Restructuring Charges	-1.06	-0.82	-0.4	-1.27	-0.8	-0.23
Gain (Loss) on Sale of Assets	1.28	1.23	0.11	0.08	-0.05	0.09
Legal Settlements	-	-	-	-	-	-0.15
Other Unusual Items	-	-	-	-0.03	0.43	-3.59
Pretax Income	-9.97	-10.34	-6.65	-2.7	2.94	-9.33
Income Tax Expense	0.24	0.24	0.11	0.09	-1.9	-3.16
Earnings From Continuing Operations	-10.21	-10.58	-6.76	-2.78	4.84	-6.17
Net Income to Company	-10.21	-10.58	-6.76	-2.78	4.84	-6.17
Minority Interest in Earnings	-0.46	-0.12	-	-	-	-
Net Income	-10.67	-10.7	-6.76	-2.78	4.84	-6.17
Net Income to Common	-10.67	-10.7	-6.76	-2.78	4.84	-6.17
Shares Outstanding (Basic)	43	43	43	39	34	30
Shares Outstanding (Diluted)	43	43	43	39	36	30
Shares Change (YoY)	1.57%	1.86%	10.09%	6.35%	19.27%	33.96%
EPS (Basic)	-0.25	-0.25	-0.16	-0.07	0.14	-0.20
EPS (Diluted)	-0.25	-0.25	-0.16	-0.07	0.13	-0.20
Free Cash Flow	26.59	25.34	25.07	30.13	17.18	12.72
Free Cash Flow Per Share	0.61	0.58	0.59	0.78	0.47	0.42
Gross Margin	72.38%	72.21%	71.97%	72.65%	73.98%	70.16%
Operating Margin	-1.31%	-1.72%	0.57%	1.91%	4.37%	-1.24%
Profit Margin	-4.03%	-4.36%	-2.75%	-1.31%	3.79%	-6.54%
Free Cash Flow Margin	10.03%	10.33%	10.19%	14.23%	13.46%	13.47%
EBITDA	43.58	41.25	45.99	40.15	24.4	13.84
EBITDA Margin	16.45%	16.81%	18.70%	18.96%	19.11%	14.66%
D&A For EBITDA	47.04	45.48	44.58	36.1	18.83	15.01
EBIT	-3.46	-4.23	1.41	4.05	5.57	-1.17
EBIT Margin	-1.31%	-1.72%	0.57%	1.91%	4.37%	-1.24%
Revenue as Reported	264.97	245.36	245.92	211.68	139.86	102.35

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q